Adaptive Immunity
21 – 30 of 55
- show: 10
- |
- sort: year (new to old)
Close
Embed this list
<iframe src=" "
width=" "
height=" "
allowtransparency="true"
frameborder="0">
</iframe>
- 2021
-
Mark
Safety and immunogenicity of a prototype recombinant alpha-like protein subunit vaccine (GBS-NN) against Group B Streptococcus in a randomised placebo-controlled double-blind phase 1 trial in healthy adult women
(
- Contribution to journal › Article
-
Mark
Proteome profiling of recombinant DNase therapy in reducing NETs and aiding recovery in COVID-19 patients
(
- Contribution to journal › Article
-
Mark
Genomic and phenotypic evolution of achromobacter xylosoxidans during chronic airway infections of patients with cystic fibrosis
(
- Contribution to journal › Article
-
Mark
The Maternal Group B Streptococcus Alpha-Like Protein Subunit Vaccine GBS-NN Targets Homotypic and Heterotypic Strains, Confers Opsonophagocytic Killing and Prevents in vitro Invasion of Human Epithelial Cells
2021) p.1-58(
- Working paper/Preprint › Preprint in preprint archive
-
Mark
Rotavirus infection causes mesenteric lymph node hypertrophy independently of type I interferon or TNF-α in mice
(
- Contribution to journal › Article
- 2020
-
Mark
Mycophenolate mofetil for systemic sclerosis : Drug exposure exhibits considerable inter-individual variation-a prospective, observational study
(
- Contribution to journal › Article
-
Mark
Immune Profiling of Human Gut-Associated Lymphoid Tissue Identifies a Role for Isolated Lymphoid Follicles in Priming of Region-Specific Immunity
(
- Contribution to journal › Article
-
Mark
Covalent Functionalization of Bioengineered Polyhydroxyalkanoate Spheres Directed by Specific Protein-Protein Interactions
(
- Contribution to journal › Article
- 2019
-
Mark
Wnt5a is a TLR2/4-ligand that induces tolerance in human myeloid cells
(
- Contribution to journal › Article
- 2018
-
Mark
Effects of Vedolizumab Therapy on Extraintestinal Manifestations in Inflammatory Bowel Disease
(
- Contribution to journal › Article